Michael Grey, President and CEO of SGX Pharmaceuticals,
Rings The NASDAQ Stock Market Closing Bell

Monday, April 3, 2006
at NASDAQ's MarketSite
in New York City.

SGX Pharmaceuticals

Michael Grey, President and CEO of SGX Pharmaceuticals, presides over the closing bell to celebrate its initial public offering on the NASDAQ. SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The Company's lead product candidate, Troxatyl™, is currently being evaluated in a pivotal phase II/III trial for the treatment of third-line acute myelogenous leukemia, an indication for which there is currently no approved therapy or standard of care.

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 4/3/2006 Download Hi-Res Quality Photo of this NASDAQ Market Close - Pictured: Michael Grey, President and CEO of SGX Pharmaceuticals, rings the Closing Bell These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.